{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T04:12:23Z","timestamp":1684555943055},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1038\/nrrheum.2009.76","type":"journal-article","created":{"date-parts":[[2009,5,4]],"date-time":"2009-05-04T10:20:26Z","timestamp":1241432426000},"page":"241-242","source":"Crossref","is-referenced-by-count":4,"title":["Targeted therapy for psoriatic arthritis"],"prefix":"10.1038","volume":"5","author":[{"given":"Dafna D.","family":"Gladman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFnrrheum200976_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1529-8019.2008.01215.x","volume":"22","author":"DD Gladman","year":"2009","unstructured":"Gladman, D. D. Psoriatic arthritis. Dermatol. Ther. 22, 40\u201355 (2009).","journal-title":"Dermatol. Ther."},{"key":"BFnrrheum200976_CR2","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S0140-6736(09)60140-9","volume":"373","author":"A Gottlieb","year":"2009","unstructured":"Gottlieb, A.  et al. Ustekinumab, a human interleukin 12\/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial. Lancet 373, 633\u2013640 (2009).","journal-title":"Lancet"},{"key":"BFnrrheum200976_CR3","first-page":"1422","volume":"33","author":"ER Soriano","year":"2006","unstructured":"Soriano, E. R. & McHugh, N. J. Therapies for peripheral joint disease in psoriatic arthritis. A systematic review. J. Rheumatol. 33, 1422\u20131430 (2006).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum200976_CR4","first-page":"669","volume":"11","author":"C Ribbens","year":"2000","unstructured":"Ribbens, C.  et al. Increased synovial fluid levels of interleukin-12, sCD25 and sTNF-RII\/sTNF-RI ratio delineate a cytokine pattern characteristic of immune arthropathies. Eur. Cytokine Netw. 11, 669\u2013676 (2000).","journal-title":"Eur. Cytokine Netw."},{"key":"BFnrrheum200976_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.imlet.2007.08.009","volume":"114","author":"AJ Hueber","year":"2007","unstructured":"Hueber, A. J. & McInnes, I. B. Immune regulation in psoriasis and psoriatic arthritis\u2014recent developments. Immunol. Lett. 114, 59\u201365 (2007).","journal-title":"Immunol. Lett."},{"key":"BFnrrheum200976_CR6","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1136\/ard.2007.072652","volume":"67","author":"V Ravindran","year":"2008","unstructured":"Ravindran, V., Scott, D. L. & Choy, E. H. A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis. Ann. Rheum. Dis. 67, 855\u2013859 (2008).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum200976_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/ng.311","volume":"41","author":"RP Nair","year":"2009","unstructured":"Nair, R. P.  et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-\u03baB pathways. Nat. Genet. 41, 199\u2013204 (2009).","journal-title":"Nat. Genet."},{"key":"BFnrrheum200976_CR8","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/jid.2008.233","volume":"129","author":"U H\u00fcffmeier","year":"2009","unstructured":"H\u00fcffmeier, U.  et al. Genetic variants of the IL-23R pathway: association with psoriatic arthritis and psoriasis vulgaris, but no specific risk factor for arthritis. J. Invest. Dermatol. 129, 355\u2013358 (2009).","journal-title":"J. Invest. Dermatol."},{"key":"BFnrrheum200976_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3899\/jrheum.080458","volume":"36","author":"P Rahman","year":"2009","unstructured":"Rahman, P.  et al. Association of interleukin-23R variants with psoriatic arthritis. J. Rheumatol. 36, 137\u2013140 (2009).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum200976_CR10","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1056\/NEJMoa062382","volume":"356","author":"GG Krueger","year":"2007","unstructured":"Krueger, G. G.  et al. A human interleukin-12\/23 monoclonal antibody for the treatment of psoriasis. N. Engl. J. Med. 356, 580\u2013592 (2007).","journal-title":"N. Engl. J. Med."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2009.76.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2009.76","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2009.76.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:25:03Z","timestamp":1684470303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2009.76"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["BFnrrheum200976"],"URL":"https:\/\/doi.org\/10.1038\/nrrheum.2009.76","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}